Vaylen vs Regenics: prepaid low-rate vs promotional first-month pricing
Vaylen vs Regenics compares two cash-pay telehealth platforms that both offer compounded semaglutide and tirzepatide; early verdict: Vaylen targets prepaid buyers seeking the lowest advertised monthly rate, while Regenics offers lower friction with a promotional first month and nurse-practitioner review.
See Vaylen plans from $83.25/mo
How they differ at a glance
Compare both providers across their most distinctive differences: pricing structure and billing, clinician review and timing, medication formats offered, shipping and refund policies, and regulatory disclosures about compounded products.
| Criteria | Vaylen | Regenics |
|---|---|---|
| Starting price | $83.25/mo on a 12-month semaglutide plan (annualized) | $139 first month for semaglutide; renews $199/mo |
| Billing model | Prepay full 12-month plan billed upfront; full refund if clinician declines | Promotional first month price; renews at higher monthly rate |
| Clinician review | Licensed U.S. clinicians review intake within 24 hours after prepay | Licensed nurse practitioners review intake before prescribing |
| Medication formats | Compounded semaglutide injections, oral semaglutide tablets, and tirzepatide | Compounded semaglutide and tirzepatide; adds Sermorelin peptide option |
| Shipping and extras | Free discreet shipping in 1 to 3 business days; injection kit included | Free shipping; compounded in the USA; captured page not fully verified for fees |
Pricing structure and what you actually pay
Vaylen publishes annualized headline rates that require prepaying a full 12-month plan up front: semaglutide injections from $83.25/mo (billed as $999), oral semaglutide $99/mo on the 12-month program, and tirzepatide from $149/mo. Vaylen states you pay before a clinician reviews your health form but that you receive a full refund for that billing cycle if the clinician declines to prescribe.
View Regenics promotional pricing
Regenics lists semaglutide starting at $139 for the first month with renewals at $199/month, and tirzepatide $189 first month renewing at $279 unless otherwise stated. Regenics frames this as promotional first-month pricing that increases on renewal.
What this means for buyers
- Vaylen may offer a lower effective monthly rate if you commit and prepay the 12-month plan.
- Regenics reduces upfront commitment with a promotional first month but has higher ongoing renewals.
Clinician review process and who oversees care
Vaylen describes licensed U.S. clinicians via OpenLoop Health who review intake within 24 hours after payment and bundle the clinician review into the plan price. Regenics states licensed nurse practitioners oversee every prescription and that intake is reviewed before anything is prescribed. Regenics therefore emphasizes pre-prescription clinician review without the pay-first model described by Vaylen.
Check Vaylen clinician review details
Medication formats and additional therapies
Both platforms offer compounded semaglutide and tirzepatide. Vaylen explicitly offers three formats on one platform: weekly semaglutide injections, daily oral semaglutide tablets, and weekly tirzepatide, and notes the oral tablet costs about $16/mo more on the prepaid plan than the injectable semaglutide. Regenics offers semaglutide and tirzepatide and additionally lists Sermorelin peptide therapy as an add-on option.
Shipping, refunds, and cancellation notes
Vaylen advertises free discreet shipping in 1 to 3 business days, a published full refund if the clinician declines, and a cancel-anytime statement; its model requires prepaying before clinician review and the site notes no published terms for unused portions of a prepaid year if you cancel mid-treatment. Regenics lists free shipping with medication compounded in the USA; captured page evidence for shipping and cancellation beyond that was not fully verified on the captured landing page.
Regulatory disclosure about compounded medications
Both providers state that compounded medications are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness, or quality. That regulatory note appears in both sources and should be considered when evaluating either option.
Final comparison and quick decision guide
Vaylen vs Regenics comes down to prepaid low-rate commitment versus promotional first-month access and clinician type. Vaylen is tailored to decisive buyers willing to prepay a 12-month plan to reach headline monthly rates and who accept compounded formulations and the pay-first clinician-review workflow. Regenics is aimed at buyers who prefer a lower barrier to start with a promotional first month, nurse-practitioner oversight, and access to a peptide add-on.
Choose Vaylen if you want the lowest advertised monthly rate via a prepaid 12-month plan, free discreet shipping in 1 to 3 business days, and a published full refund if the clinician declines. Choose Regenics if you prefer promotional first-month pricing with renewals at higher rates, nurse-practitioner-led review before prescribing, and a Sermorelin peptide option.